Anti-Phospho-p62 (SQSTM1) (Ser403) mAb (Clone: 4F6)

Catalog No:
MBL-D343-3

Availability: 12PM PT on Dec. 3, 2024

Monoclonal antibody Phospho-p62 (SQSTM1) (Ser403) of 100 µl targeting for IHC, WB.

Product Specifications
Application WB, IHC
Reactivity Human, Mouse
Clonality Monoclonal IgG2a ĸ
Host Rat
Immunogen synthetic peptide CKKKESLSQMLpSMGFSDEGKKK (corresponding to amino acid residues 396-410 of human p62 (SQSTM1))
Gene ID - Human

8878

Formulation PBS/50% glycerol, pH 7.2

Citations for Anti-Phospho-p62 (SQSTM1) (Ser403) mAb (Clone: 4F6) – 5 Found
Matsumoto, Gen; Wada, Koji; Okuno, Misako; Kurosawa, Masaru; Nukina, Nobuyuki. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Molecular Cell. 2011;44(2):279-89.  PubMed
Comments: Used in: WB
Matsumoto, Gen; Wada, Koji; Okuno, Misako; Kurosawa, Masaru; Nukina, Nobuyuki. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Molecular Cell. 2011;44(2):279-89.  PubMed
Comments: Used in: IHC
Kurosawa, Masaru; Matsumoto, Gen; Kino, Yoshihiro; Okuno, Misako; Kurosawa-Yamada, Mizuki; Washizu, Chika; Taniguchi, Harumi; Nakaso, Kazuhiro; Yanagawa, Toru; Warabi, Eiji; Shimogori, Tomomi; Sakurai, Takashi; Hattori, Nobutaka; Nukina, Nobuyuki. Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice. Human Molecular Genetics. 2015;24(4):1092-105.  PubMed
Comments: Used in: IHC
Yamada, Mami; Iwata, Masahiro; Warabi, Eiji; Oishi, Hisashi; Lira, Vitor A; Okutsu, Mitsuharu. p62/SQSTM1 and Nrf2 are essential for exercise-mediated enhancement of antioxidant protein expression in oxidative muscle. Faseb Journal : Official Publication Of The Federation Of American Societies For Experimental Biology. 2019;33(7):8022-8032.  PubMed
Comments: Used in: WB
Kanai, Tomotake; Kondo, Naoki; Okada, Masayasu; Sano, Hiroshige; Okumura, Go; Kijima, Yasufumi; Ogose, Akira; Kawashima, Hiroyuki; Endo, Naoto. The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3. Journal Of Orthopaedic Surgery And Research. 2020;15(1):87.  PubMed
Comments: Used in: WB